Global Studies Institute, University of Geneva, Sciences II, Quai Ernest-Ansermet 30, Case postale, 1211, Geneva, Switzerland.
School of Public Health and Health Systems, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada.
BMC Infect Dis. 2021 Aug 26;21(1):873. doi: 10.1186/s12879-021-06483-z.
Antimicrobial resistance (AMR) is among the most pressing One Health issues. While interventions and policies with various targets and goals have been implemented, evidence about factors underpinning success and failure of interventions in different sectors is lacking. The objective of this study is to identify characteristics of AMR interventions that increase their capacity to impact AMR. This study focuses on AMR interventions targeting E. coli.
We used the AMR-Intervene framework to extract descriptions of the social and ecological systems of interventions to determine factors contributing to their success.
We identified 52 scientific publications referring to 42 unique E. coli AMR interventions. We mainly identified interventions implemented in high-income countries (36/42), at the national level (16/42), targeting primarily one sector of society (37/42) that was mainly the human sector (25/42). Interventions were primarily funded by governments (38/42). Most intervention targeted a low leverage point in the AMR system, (36/42), and aimed to change the epidemiology of AMR (14/42). Among all included publications, 55% (29/52) described at least one success factor or obstacle (29/52) and 19% (10/52) identified at least one success factor and one obstacle. Most reported success factors related to communication between the actors and stakeholders and the role of media, and stressed the importance of collaboration between disciplines and external partners. Described obstacles covered data quality, access to data and statistical analyses, and the validity of the results.
Overall, we identified a lack of diversity regarding interventions. In addition, most published E. coli interventions were poorly described with limited evidence of the factors that contributed to the intervention success or failure. Design and reporting guidelines would help to improve reporting quality and provide a valuable tool for improving the science of AMR interventions.
抗菌药物耐药性(AMR)是最紧迫的“同一健康”问题之一。虽然已经实施了针对各种目标和目的的干预措施和政策,但缺乏关于不同部门干预措施成功和失败背后因素的证据。本研究的目的是确定能够增强其对抗 AMR 影响能力的 AMR 干预措施的特征。本研究重点关注针对大肠杆菌的 AMR 干预措施。
我们使用 AMR-Intervene 框架提取干预措施的社会和生态系统描述,以确定有助于其成功的因素。
我们确定了 52 篇科学出版物,其中涉及 42 个独特的大肠杆菌 AMR 干预措施。我们主要发现了在高收入国家(36/42)、国家层面(16/42)实施的干预措施,主要针对社会的一个部门(37/42),主要是人类部门(25/42)。干预措施主要由政府(38/42)资助。大多数干预措施针对 AMR 系统中的低杠杆点(36/42),旨在改变 AMR 的流行病学(14/42)。在所有纳入的出版物中,55%(29/52)描述了至少一个成功因素或障碍(29/52),19%(10/52)确定了至少一个成功因素和一个障碍。大多数报道的成功因素与行为者和利益相关者之间的沟通以及媒体的作用有关,并强调了学科之间和外部合作伙伴之间合作的重要性。描述的障碍包括数据质量、数据获取和统计分析以及结果的有效性。
总体而言,我们发现干预措施的多样性不足。此外,大多数已发表的大肠杆菌干预措施描述得很差,缺乏导致干预成功或失败的因素的证据。设计和报告指南将有助于提高报告质量,并为改善 AMR 干预措施的科学提供有价值的工具。